Re: ZEN-3694 mCRPC Trial Status
in response to
by
posted on
Nov 18, 2017 06:46PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
ZEN-3694 Single Agent Trial status now listed asĀ completed on ClinicalTrials.gov as of an updated posted 11/17/2017.
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer